We are live on
!
Find out more
ASP
Adams Street Partners Portfolio holdings
AUM
$260M
1-Year Est. Return
30.38%
This Fund
S&P 500
This Quarter
Est. Return
+9.37%
1 Year Est. Return
+30.38%
3 Year Est. Return
+351.96%
5 Year Est. Return
+202.05%
10 Year Est. Return
+1,159.77%
AUM
$142M
AUM Growth
+$29M
(+26%)
Cap. Flow
+$21.9M
Cap. Flow
% of AUM
15.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
1
Reduced
1
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Samsara
IOT
|
+$22.9M |
| 2 |
Paymentus
PAY
|
+$7.79M |
| 3 |
DoorDash
DASH
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VCSA
Vacasa, Inc. Class A Common Stock
VCSA
|
+$5.05M |
| 2 |
PVLA
Palvella Therapeutics
PVLA
|
+$2.6M |
| 3 |
Kanzhun
BZ
|
+$1.67M |
| 4 |
TEM
Tempus AI
TEM
|
+$447K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 85.12% |
| 2 | Healthcare | 13.98% |
| 3 | Consumer Discretionary | 0.91% |
| 4 | Communication Services | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rimini Street
RMNI
$408M
| $88.8M | 62.57% |
23,565,433
| – | – |
|
|
2
Samsara
IOT
$19.3B
| $22M | 15.5% |
+553,085
| New | +$22.9M |
|
3
Corvus Pharmaceuticals
CRVS
$1.1B
| $13.1M | 9.23% |
3,275,616
| – | – |
|
|
4
Paymentus
PAY
$3.63B
| $10M | 7.05% |
305,568
+232,600
| +319% | +$7.79M |
|
|
PVLA
5
Palvella Therapeutics
PVLA
$1.98B
| $6.74M | 4.75% |
298,986
-110,680
| -27% | -$2.6M |
|
|
6
DoorDash
DASH
$75.3B
| $1.29M | 0.91% |
+5,214
| New | +$1.05M |
|
|
7
Kanzhun
BZ
$6.89B
| – | – |
-87,157
| Closed | -$1.67M |
|
|
TEM
8
Tempus AI
TEM
$7.69B
| – | – |
-9,266
| Closed | -$447K |
|
|
VCSA
9
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| – | – |
-938,221
| Closed | -$5.05M |
|
Similar funds
MA
LIM
WI
SHCM
BOC
LCM
ICM
HIA
Adams Street Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Adams Street Partners held 9 positions worth $142M, up 26% from $113M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Adams Street Partners deployed $21.9M of net new capital in Q2 2025, opening 2 new positions and adding to 1 existing holding. Its largest new stake was Samsara: 553,085 shares worth $22M.
By sector, the portfolio is most concentrated in Technology at 85% of assets, up from 74% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Palvella Therapeutics, an estimated $2.6M trimmed.
- Adams Street Partners's largest Q2 2025 buy was Samsara: 553,085 shares worth $22M.
- Adams Street Partners added most to Paymentus in Q2 2025, an estimated $7.79M increase.
- Adams Street Partners's biggest Q2 2025 reduction was Palvella Therapeutics, cutting an estimated $2.6M.
- Adams Street Partners fully exited Vacasa, Inc. Class A Common Stock in Q2 2025, selling an estimated $5.05M.
- Adams Street Partners's ten largest holdings make up 100% of its $142M portfolio in Q2 2025.
- Adams Street Partners opened 2 new positions and closed 3 in Q2 2025.
- Adams Street Partners's portfolio value rose 26% quarter-over-quarter to $142M.
Based on Adams Street Partners's 13F filing for Q2 2025, filed 13 Aug 2025.